<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04984213</url>
  </required_header>
  <id_info>
    <org_study_id>SEI-004</org_study_id>
    <nct_id>NCT04984213</nct_id>
  </id_info>
  <brief_title>Study of the Long-Term Outcomes of Posterior Spinal Fixation With the Karma Device</brief_title>
  <official_title>CORTI-FIX: Clinical and Radiographic Outcomes Following Lumbar Interbody Placement With Posterior Minimally Invasive Intra-Laminar PEEK Ratcheting Fixation Device</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Spinal Elements</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Spinal Elements</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>Yes</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The primary objective of this clinical study is to measure fusion rate in patients at 12&#xD;
      months following lumbar fusion in combination with posterior fixation using the Karma®&#xD;
      device.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">August 15, 2021</start_date>
  <completion_date type="Anticipated">December 31, 2024</completion_date>
  <primary_completion_date type="Anticipated">December 31, 2022</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Fusion Rate</measure>
    <time_frame>12 months</time_frame>
    <description>Interbody Fusion Rate</description>
  </primary_outcome>
  <enrollment type="Anticipated">100</enrollment>
  <condition>Lumbar Disc Disease</condition>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Karma Posterior Fixation Device</intervention_name>
    <description>Posterior Fixation</description>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Subjects needing a lumbar fusion surgery&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          1. Skeletally mature and age ≥ 18 years of age&#xD;
&#xD;
          2. Appropriate patient as determined by the Investigator for anterior or lateral approach&#xD;
             to lumbar interbody fusion surgery with planned posterior fixation to treat&#xD;
             degenerative disc disease in one or two adjacent vertebral levels between L2 and S1.&#xD;
&#xD;
          3. Failed at least six months of conservative treatment. This may or may not include any&#xD;
             of the following,&#xD;
&#xD;
               1. Spinal injections&#xD;
&#xD;
               2. Chiropractic care&#xD;
&#xD;
               3. Physical therapy&#xD;
&#xD;
               4. Activity modification and/or with anti-inflammatory medications&#xD;
&#xD;
          4. Oswestry Low Back Pain Disability Questionnaire score of at least 30%&#xD;
&#xD;
          5. Visual Analog Scale (VAS) for back/hip/lower extremity pain ranking at a minimum at&#xD;
             least 3/10 (30%)&#xD;
&#xD;
          6. Psychosocially, mentally and physically able to fully comply with this protocol&#xD;
             including adhering to follow-up schedule, study requirements with a signed informed&#xD;
             consent with a study collaborator present at the time of signing to ensure compliance.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          1. Patients with greater than two levels of degenerative disease or deformity for&#xD;
             INTENDED operative levels.&#xD;
&#xD;
          2. Previous fusion or total disc replacement at the intended level/s&#xD;
&#xD;
          3. Known allergy to implant and instrument materials&#xD;
&#xD;
          4. Clinically compromised vertebral bodies at the affected level(s) due to current or&#xD;
             past trauma&#xD;
&#xD;
          5. Degenerative spondylolisthesis of grade &gt;2&#xD;
&#xD;
          6. Isthmic spondylolisthesis&#xD;
&#xD;
          7. Back or leg pain of unknown etiology&#xD;
&#xD;
          8. Active systemic infection or infection at the location planned surgery&#xD;
&#xD;
          9. Active or suspected malignancy. If symptom free for 2 years, patients with prior&#xD;
             malignancy may be included.&#xD;
&#xD;
         10. Morbid obesity defined as a body mass index &gt; 40&#xD;
&#xD;
         11. Patient being treated for other specific medical conditions that may affect bone&#xD;
             density or the ability to obtain fusion (ie: steroids, etc)&#xD;
&#xD;
         12. Pregnant or have plans to become pregnant in the next year.&#xD;
&#xD;
         13. Currently a prisoner&#xD;
&#xD;
         14. Patient has any condition, that in the opinion of the Investigator, would prohibit the&#xD;
             patient from complying with the protocol&#xD;
&#xD;
         15. Participation in a concurrent clinical study.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <verification_date>July 2021</verification_date>
  <study_first_submitted>July 20, 2021</study_first_submitted>
  <study_first_submitted_qc>July 20, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">July 30, 2021</study_first_posted>
  <last_update_submitted>July 20, 2021</last_update_submitted>
  <last_update_submitted_qc>July 20, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">July 30, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

